Alvimopan vs placebo to reduce bowel slowdown after bladder surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether alvimopan, a medicine given around the time of bladder removal surgery, can help your bowels start working sooner after surgery compared with a placebo (inactive pill). It may help shorten recovery by reducing bowel-related side effects on an enhanced recovery plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a radical cystectomy (bladder removal) with urinary diversion using either open or robotic surgery
- You are between 18 and 85 years old
- Your overall health is rated as ASA class 1 to 4
- Your urinary diversion will be an ileal conduit or an ileal neobladder
- You can understand the study and agree to sign informed consent
- You are not having a partial cystectomy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a patient-centered coaching and preparation program before bladder surgery (cystectomy) to help you get ready for surgery and recovery. It may be especially helpful for people having urinary diversion using an ileal conduit or ileal neobladder.
This trial compares two different surgical approaches during bladder removal surgery: using a stent or not, and using a drug called alvimopan or not. Alvimopan helps the bowels work normally after surgery.
This trial compares two ways surgeons rebuild a new bladder using either sigmoid colon tissue or ileum (small intestine) tissue. It aims to see which option is safer and works better for people having bladder cancer surgery.
This study tests how certain drugs affecting the endocannabinoid system (a natural body signaling pathway) affect bladder muscle function in people with bladder cancer who are preparing for or undergoing surgery. Researchers hope this research will help preserve bladder function during cancer treatment.
This trial studies whether a “prostate-sparing” radical cystectomy is safe and effective for bladder cancer patients who are having surgery. It aims to see if this approach can treat bladder cancer while reducing prostate-related side effects.
This trial uses a lab-grown version of your tumor (an organoid) to see which chemotherapy might work best for you after bladder cancer surgery. It helps doctors choose the most effective treatment for each person.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.